Transcat (TRNS) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Transcat (TRNS) do?
Transcat Inc (TRNS) is a U.S.-listed company in Industrials (Specialty Business Services). What it does: Calibrates, inspects, and repairs precision test instruments across accredited service facilities. Calibrates precision measurement instruments in accredited laboratories and distributes specialized testing equipment. It is worth $917.25M on the market and sold $362.55M over the last year.
- Market cap
- $917.25M
- P/E ratio
- 202.2×
- Annual sales
- $362.55M
- Sector
- Industrials
- Industry
- Specialty Business Services
- Brief updated
- Nov 17, 2026
Brands and businesses behind TRNS
- Pipette.com: Sells laboratory liquid handling tools and pipette calibration services to life science researchers.
TRNS’s flags, in plain English
Each flag is a number from Transcat’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Stupid Cash
Can pay this year's bills 2.6 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Low debt
Low debt, only 49% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Still Climbing
Sales up 13.9% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Priced for Perfection
Priced at 202.2 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
1 more green flag and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about TRNS
How big is Transcat?
Transcat’s market cap is $917.25M: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $362.55M: what customers paid the company over the last year, before any costs.
What is TRNS’s P/E ratio?
TRNS’s P/E ratio is 202.2×. Investors pay about 202.2 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with TRNS?
The company relies on recurring compliance spending from life science and aerospace customers who can delay calibrations during downturns. That is one risk on Transcat’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Transcat’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. TRNS’s filings on SEC.gov. The Margin Monkey is research, not advice.
